drugset / Trial / NCT02700347

Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers

NCT02700347

Phase 1 Completed 12 enrolled National University Hospital, Singapore
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the bactericidal activity against Mycobacterium tuberculosis of pyrazinamide in combination with allopurinol. Pharmacokinetics (PK) and whole blood bactericidal activity (WBA) will be measured in healthy volunteers following administration of pyrazinamide alone and in combination with allopurinol.

Timeline

Start
2016-02
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule 100 mg
Subject Pyrazinamide Small molecule 10 mg/kg
Subject Pyrazinamide Small molecule 25 mg/kg
Subject Pyrazinamide Small molecule 35 mg/kg

Indications